Gut Proteobacteria Influence Cocaine Addiction via Glycine Metabolism in Mice
Cocaine exposure alters gut microbiome composition, increasing Proteobacteria and depleting glycine, which affects neuroplasticity and cocaine self-administration in mice.
Phase III
Neurology / Addiction
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
Pharma teams should consider the gut microbiome's role in addiction treatment development, potentially leading to novel therapeutic strategies.
Why it matters
This research underscores the potential of the gut-brain axis as a novel target for addiction therapies, particularly in cocaine addiction. As the understanding of microbiome modulation evolves, pharmaceutical companies may need to pivot their strategies to incorporate these insights into new treatment developments.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor ongoing research into microbiome-targeted therapies for addiction and any clinical trials that may arise from these findings.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.